Atherosclerosis (AS) is the most
common cardiovascular disease
(CVD). Currently, it is widely believed that R-TFA and I-TFA may cause
different biological effects. In the present study, we aim to elucidate
the effect of mixed R-TFA derived from butter on the development of
AS in high-fat diet-fed ApoE–/– mice and
find the possible mechanism. It was shown that butter-derived R-TFA
promoted dyslipidemia, reduced thoracic and abdominal aorta diameters,
and induced aortic lipid deposition and atherosclerotic lesions in
high-fat diet-fed ApoE–/– mice. Meanwhile,
butter-derived R-TFA affected the serum lipid profile of high-fat
diet-fed ApoE–/– mice and the lipid metabolism
of human umbilical vein endothelial cells (HUVECs). Through lipidomic
techniques, we found that butter-derived R-TFA had a significant effect
on the glycerophospholipid metabolic pathway. In conclusion, our results
demonstrated that butter-derived R-TFA does not alleviate but promotes
atherosclerotic lesions in high-fat diet-fed ApoE–/– mice and that the glycerophospholipid metabolic pathway plays a
major role in this pro-atherosclerotic effect.